Najarian J S, Frey D J, Matas A J, Gillingham K J, So S S, Cook M, Chavers B, Mauer S M, Nevins T E
Department of Surgery, University of Minnesota Medical School, Minneapolis.
Ann Surg. 1990 Sep;212(3):353-65; discussion 366-7. doi: 10.1097/00000658-199009000-00014.
The timing of renal transplantation in infants is controversial. Between 1965 and 1989, 79 transplants in 75 infants less than 2 years old were performed: 23 who were 12 months or younger, 52 who were older than 12 months; 63 donors were living related, 1 was living unrelated, and 15 were cadaver donors; 75 were primary transplants and 4 were retransplants. Infants were considered for transplantation when they were on, or about to begin, dialysis. All had intra-abdominal transplants with arterial anastomosis to the distal aorta. Sixty-four per cent are alive with functioning grafts. The most frequent etiologies of renal failure were hypoplasia (32%) and obstructive uropathy (20%); oxalosis was the etiology in 11%. Since 1983 patient survival has been 95% and 91% at 1 and 5 years; graft survival has been 86% and 73% at 1 and 5 years. For cyclosporine immunosuppressed patients, patient survival is 100% at 1 and 5 years; graft survival is 96% and 82% at 1 and 5 years. There was no difference in outcome between infants who were 12 months or younger versus those who were aged 12 to 24 months; similarly there was no difference between infants and older children. Sixteen (21%) patients died: 5 after operation from coagulopathy (1) and infection (4); and 11 late from postsplenectomy sepsis (4), recurrent oxalosis (3), infection (2), and other causes (2). Routine splenectomy is no longer done. There has not been a death from infection in patients transplanted since 1983. Rejection was the most common cause of graft loss (in 15 patients); other causes included death (with function) (7), recurrent oxalosis (3), and technical complications (3). Overall 52% of patients have not had a rejection episode; mean creatinine level in patients with functioning grafts is 0.8 +/- 0.2 mg/dL. Common postoperative problems include fever, atelectasis, and ileus. At the time of their transplants, the infants were small for age; but with a successful transplant, their growth, head circumference, and development have improved. Transplantation in infants requires an intensive multidisciplinary approach but yields excellent short- and long-term survival rates that are no different from those seen in older children or adults. Living donors should be used whenever possible. Patients with a successful transplantation experience improved growth and development, with excellent rehabilitation.
婴儿肾移植的时机存在争议。1965年至1989年间,对75名2岁以下婴儿进行了79例肾移植:23例年龄在12个月及以下,52例年龄大于12个月;63例供体为活体亲属,1例为活体非亲属,15例为尸体供体;75例为初次移植,4例为再次移植。当婴儿正在接受透析或即将开始透析时,会考虑进行移植。所有婴儿均接受腹腔内移植,动脉与腹主动脉远端吻合。64%的患者移植肾存活且功能良好。肾衰竭最常见的病因是肾发育不全(32%)和梗阻性尿路病(20%);草酸中毒是11%的病因。自1983年以来,患者1年和5年的生存率分别为95%和91%;移植肾1年和5年的生存率分别为86%和73%。对于接受环孢素免疫抑制的患者,1年和5年的患者生存率均为100%;移植肾1年和5年的生存率分别为96%和82%。12个月及以下的婴儿与12至24个月的婴儿在预后方面没有差异;同样,婴儿与大龄儿童之间也没有差异。16例(21%)患者死亡:5例术后死于凝血病(1例)和感染(4例);11例后期死于脾切除术后败血症(4例)、复发性草酸中毒(3例)、感染(2例)及其他原因(2例)。现在不再常规进行脾切除术。自1983年以来,移植患者没有因感染死亡的情况。移植肾丢失最常见的原因是排斥反应(15例患者);其他原因包括死亡(移植肾有功能)(7例)、复发性草酸中毒(3例)和技术并发症(3例)。总体而言,52%的患者没有发生排斥反应;移植肾有功能的患者肌酐平均水平为0.8±0.2mg/dL。常见的术后问题包括发热、肺不张和肠梗阻。这些婴儿在接受移植时年龄小;但移植成功后,他们的生长、头围和发育都有所改善。婴儿肾移植需要多学科的强化治疗方案,但能获得与大龄儿童或成人相同的优异短期和长期生存率。应尽可能使用活体供体。移植成功的患者生长和发育得到改善,康复情况良好。